Omnicell (OMCL) Total Current Liabilities (2010 - 2026)
Omnicell's (OMCL) quarterly Total Current Liabilities came in at $447.4 million in Q2 2026, down 24.72% year-over-year from $594.4 million in Q2 2025, and down 7.37% quarter-over-quarter from $483.0 million in Q1 2026.
Analysis
Omnicell (OMCL) Total Current Liabilities (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Total Current Liabilities for 17 consecutive years, with $447.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 24.72% year-over-year to $447.4 million in Q2 2026; TTM through Jun 2026 was $447.4 million, a 24.72% decrease from a year earlier, with the FY2025 full-year figure at $476.6 million, down 19.99% from the prior year.
- Total Current Liabilities was $447.4 million for Q2 2026 at Omnicell, down from $483.0 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $961.5 million in Q3 2024 and troughed at $367.8 million in Q4 2023.
- A 5-year average of $507.6 million and a median of $450.7 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 225.38% in 2022 and plunged 52.51% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $428.4 million in 2022, then slipped by 14.16% to $367.8 million in 2023, then soared by 61.96% to $595.7 million in 2024, then dropped by 19.99% to $476.6 million in 2025, then fell by 6.12% to $447.4 million in 2026.
- The last three Total Current Liabilities figures came in at $447.4 million (Q2 2026), $483.0 million (Q1 2026), and $476.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 1.40 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 447.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 447.44 Mn |
| Mar 31, 2026 | 483.05 Mn |
| Dec 31, 2025 | 476.61 Mn |
| Sep 30, 2025 | 456.59 Mn |
| Jun 30, 2025 | 594.39 Mn |
| Mar 31, 2025 | 607.53 Mn |
| Dec 31, 2024 | 595.68 Mn |
| Sep 30, 2024 | 961.52 Mn |
| Jun 30, 2024 | 407.12 Mn |
| Mar 31, 2024 | 416.36 Mn |
| Dec 31, 2023 | 367.79 Mn |
| Sep 30, 2023 | 369.36 Mn |
| Jun 30, 2023 | 370.16 Mn |
| Mar 31, 2023 | 453.97 Mn |
| Dec 31, 2022 | 428.45 Mn |
| Sep 30, 2022 | 376.68 Mn |
| Jun 30, 2022 | 373.51 Mn |
| Mar 31, 2022 | 951.01 Mn |
| Dec 31, 2021 | 876.16 Mn |
| Sep 30, 2021 | 338.66 Mn |